National Vision Holdings, Inc. (EYE) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-07-04..
Quick ratio
Overview →Financial period ending 2026-07-04; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-07-04. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 383.03M USD | Liabilities, Current |
| Cash and equivalents | 36.00M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 34.90M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 122.59M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-07-04 | (m) | $383.03M | $36.00M | (m) | $34.90M | $122.59M | (m) |
| 2026-04-04 | (m) | $418.49M | $67.90M | (m) | $43.99M | $107.71M | (m) |
| 2026-01-03 | (m) | $412.41M | $38.71M | (m) | $57.32M | $89.32M | (m) |
| 2025-09-27 | (m) | $416.96M | $56.03M | (m) | $46.13M | $88.01M | (m) |
| 2025-06-28 | (m) | $418.25M | $48.47M | (m) | $45.96M | $89.65M | (m) |
| 2025-03-29 | (m) | $468.21M | $80.02M | (m) | $53.17M | $88.57M | (m) |
| 2024-12-28 | (m) | $468.27M | $73.95M | (m) | $49.94M | $93.92M | (m) |
| 2024-09-28 | (m) | $426.12M | $81.15M | (m) | $46.80M | $87.59M | (m) |
| 2024-06-29 | (m) | $663.16M | $179.51M | (m) | $61.07M | $90.96M | (m) |
| 2024-03-30 | (m) | $375.01M | $150.05M | (m) | $74.27M | $118.56M | (m) |
| 2023-12-30 | (m) | $397.70M | $149.90M | (m) | $86.85M | $119.91M | (m) |
| 2023-09-30 | (m) | $373.53M | $265.81M | (m) | $76.64M | $120.58M | (m) |
| 2023-07-01 | (m) | $363.23M | $254.65M | (m) | $78.90M | $120.87M | (m) |
| 2023-04-01 | (m) | $361.76M | $246.91M | (m) | $80.05M | $123.52M | (m) |
| 2022-12-31 | (m) | $344.26M | $229.43M | (m) | $79.89M | $123.16M | (m) |
| 2022-10-01 | (m) | $336.63M | $256.21M | (m) | $63.82M | $122.03M | (m) |
| 2022-07-02 | (m) | $353.79M | $254.38M | (m) | $63.77M | $129.49M | (m) |
| 2022-04-02 | (m) | $345.41M | $314.64M | (m) | $62.24M | $127.40M | (m) |
| 2022-01-01 | (m) | $343.80M | $305.80M | (m) | $55.70M | $123.67M | (m) |
| 2021-10-02 | (m) | $348.84M | $439.12M | (m) | $54.08M | $124.64M | (m) |
| 2021-07-03 | (m) | $370.48M | $408.30M | (m) | $54.73M | $120.86M | (m) |
| 2021-04-03 | (m) | $359.83M | $453.79M | (m) | $60.04M | $119.53M | (m) |
| 2021-01-02 | (m) | $328.68M | $373.90M | (m) | $57.99M | $111.27M | (m) |
| 2020-09-26 | (m) | $356.05M | $377.01M | (m) | $49.68M | $111.70M | (m) |
| 2020-06-27 | (m) | $311.94M | $256.29M | (m) | $58.45M | $117.86M | (m) |
| 2020-03-28 | (m) | $287.46M | $263.15M | (m) | $27.60M | $130.37M | (m) |
| 2019-12-28 | (m) | $273.18M | $39.34M | (m) | $44.48M | $127.56M | (m) |
| 2019-09-28 | (m) | $303.90M | $94.09M | (m) | $50.66M | $111.89M | (m) |
| 2019-06-29 | (m) | $288.28M | $82.78M | (m) | $57.44M | $105.66M | (m) |
| 2019-03-30 | (m) | $297.67M | $72.51M | (m) | $58.02M | $111.94M | (m) |
| 2018-12-29 | (m) | $211.65M | $17.13M | (m) | $50.73M | $116.02M | (m) |
| 2018-09-29 | (m) | $197.20M | $48.88M | (m) | $38.88M | $99.28M | (m) |
| 2018-06-30 | (m) | $189.26M | $34.64M | (m) | $45.08M | $94.91M | (m) |
| 2018-03-31 | (m) | $221.66M | $58.43M | (m) | $41.74M | $93.68M | (m) |
| 2017-12-31 | (m) | $197.32M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-30 | (m) | $211.31M | $4.21M | (m) | $43.19M | $91.15M | (m) |
| 2017-09-30 | (m) | $219.18M | $27.62M | (m) | $39.11M | $89.37M | (m) |
| 2017-07-01 | (m) | (m) | $24.86M | (m) | (m) | (m) | (m) |
| 2017-04-01 | (m) | (m) | $29.91M | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $199.68M | $4.95M | (m) | $34.37M | $87.06M | (m) |
| 2016-10-01 | (m) | (m) | $23.74M | (m) | (m) | (m) | (m) |
| 2016-01-02 | (m) | (m) | $5.59M | (m) | (m) | (m) | (m) |
| 2015-01-03 | (m) | (m) | $6.83M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |